PF 04929113,
PF-04929113,
PF04929113,
SNX-5422,
908115-27-5,
PF-04929113,
SNX-5422,
SNX 5422,
SNX5422,
PF-04929113 (SNX-5422),
UNII-BF52J69Q8T,
PF 04929113,
BF52J69Q8T,
PF-4929113,
PF04929113,
cc-40,
MLS006011083,
SCHEMBL1220790,
SCHEMBL1220791,
CHEMBL1195136,
SCHEMBL15604989,
DTXSID50238270,
C25H30F3N5O4,
BCPP000065,
HMS3656B09,
BCP02427,
EX-A2343,
ABP000737,
s2656,
ZINC95616595,
AKOS027276395,
ZINC100071931,
ZINC252517142,
API0008143,
CS-0272,
DB06070,
RL05706,
SB16643,
SNX-5422 /,
NCGC00346640-01,
NCGC00386184-02,
Glycine, trans-4-((2-(aminocarbonyl)-5-(4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1H-indazol-1-yl)phenyl)amino)cyclohexyl ester,
HY-10213,
SC-85704,
SMR004702871,
SW220153-1,
X7589,
SNX-5422(PF04929113),
W-5830,
PF 04929113, SNX 5422,
PF-0492911 - SNX-5422,
PF-04929113; SNX-5422,
J-521414,
BRD-K73197500-066-01-7,
SNX-5422, PF-04929113, 908115-27-5,
(1r,4r)-4-((2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)phenyl)amino)cyclohexyl 2-aminoacetate,
(1r,4r)-4-((2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)phenyl)amino)cyclohexyl glycinate,
(1r,4r)-4-({2-carbamoyl-5-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]phenyl}amino)cyclohexyl 2-aminoacetate,
[4-[2-carbamoyl-5-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]anilino]cyclohexyl] 2-aminoacetate,
4-((2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)phenyl)amino)cyclohexyl glycinate,
Glycine Trans-4-((2-(aminocarbonyl)-5-(4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1h-indazol-1-yl)phenyl)amino)cycloh exyl ester,
glycine trans-4-((2-(aminocarbonyl)-5-(4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1h-indazol-1-yl)phenyl)amino)cyclohexyl ester,
SNX-5422|||[4-[2-Carbamoyl-5-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]anilino]cyclohexyl] 2-aminoacetate,
D07MPL,
SNX-54227 Mesylate salt,
A4065,
A11074,